CLEMIZOLE - search results

merck sharp & dohme (israel - 1996) company ltd, israel - posaconazole - suspension - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective antifungal therapy. noxafil is also indicated for prophylaxis of invasive fungal infections in the following patients : - patients receiving remission- induction chemotherapy for acute myelogenous leukemia ( aml) or myelodysplastic syndromes ( mds ) expected to result in prologed neutropenia and who are at high risk of developing invasive fungal infections - hematopoietic stem cell transplant ( hsct) recipients who are undergoing high - dose immunosuppressive therapy for graft versus host disease and who are at high risk of developing invasive fungal infections. zygomycosis in patients intolerant of or with disease that is refractory to alternative therapy

United States - English - NLM (National Library of Medicine)

ketoconazole tablet

physicians total care, inc. - ketoconazole (unii: r9400w927i) (ketoconazole - unii:r9400w927i) - ketoconazole 200 mg - ketoconazole tablets are indicated for the treatment of the following systemic fungal infections: candidiasis, chronic mucocutaneous candidiasis, oral thrush, candiduria, blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. ketoconazole tablets should not be used for fungal meningitis because it penetrates poorly into the cerebral-spinal fluid. ketoconazole tablets are also indicated for the treatment of patients with severe recalcitrant cutaneous dermatophyte infections who have not responded to topical therapy or oral griseofulvin, or who are unable to take griseofulvin. coadministration of terfenadine or astemizole with ketoconazole tablets is contraindicated. (see box warning, warnings, and precautions sections.) concomitant administration of ketoconazole tablets with cisapride is contraindicated. (see box warning, warnings, and precautions sections.) concomitant administration of ketoconazole tablets with oral triazolam is contraindicated. (see precau

United States - English - NLM (National Library of Medicine)

ketoconazole tablet

state of florida doh central pharmacy - ketoconazole (unii: r9400w927i) (ketoconazole - unii:r9400w927i) - ketoconazole 200 mg - ketoconazole tablets are indicated for the treatment of the following systemic fungal infections: candidiasis, chronic mucocutaneous candidiasis, oral thrush, candiduria, blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. ketoconazole tablets should not be used for fungal meningitis because it penetrates poorly into the cerebral-spinal fluid. ketoconazole tablets are also indicated for the treatment of patients with severe recalcitrant cutaneous dermatophyte infections who have not responded to topical therapy or oral griseofulvin, or who are unable to take griseofulvin. coadministration of terfenadine or astemizole with ketoconazole tablets is contraindicated. (see box warning, warnings, and precautions.) concomitant administration of ketoconazole tablets with cisapride is contraindicated. (see box warning, warnings and precautions.) concomitant administration of ketoconazole tablets with oral triazolam is contraindicated. (see precautions.) ketoconazole is contrain

United States - English - NLM (National Library of Medicine)

ketoconazole tablet

rebel distributors corp - ketoconazole (unii: r9400w927i) (ketoconazole - unii:r9400w927i) - ketoconazole 200 mg - ketoconazole tablets are indicated for the treatment of the following systemic fungal infections: candidiasis, chronic mucocutaneous candidiasis, oral thrush, candiduria, blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. ketoconazole tablets should not be used for fungal meningitis because it penetrates poorly into the cerebral-spinal fluid. ketoconazole tablets are also indicated for the treatment of patients with severe recalcitrant cutaneous dermatophyte infections who have not responded to topical therapy or oral griseofulvin, or who are unable to take griseofulvin. coadministration of terfenadine or astemizole with ketoconazole tablets is contraindicated. (see box warning, warnings, and precautions sections.) concomitant administration of ketoconazole tablets with cisapride is contraindicated. (see box warning, warnings, and precautions sections.) concomitant administration of ketoconazole tablets with oral triazolam is contraindicated. (see precautions section